Medplus Health Services Share Price

Medplus Health Services Share Price

  • 870.90-4.96 (-0.57%)
  • Live
  • As On: 12 Jun, 2026, 12:39 PM IST
Loading...
Open887.00
High887.00
Low863.00
Prev Close875.85
Volume57,490
VWAP(₹)869.84

Key Metrics

PE Ratio(x)47.42
EPS - TTM(₹)18.30
MCap(₹ Cr.)10,429.15
MCap Rank5
PB Ratio(x)5.23
Div Yield(%)-
Face Value(₹)2.00
52W High(₹)1,022.20
52W Low(₹)732.00
MCap/Sales1.46
Beta(1 Month)-
BV/Share(₹)164.48

Medplus Health Serv share price insights

Rank 349 - ET 5002025 ranking
  • Employee & Interest Expense

    Company has spent 1.75% of its operating revenues towards interest expenses and 12.83% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Medplus Health Serv Share Price Update

    Medplus Health Services Ltd. share price moved down by -0.57% from its previous close of Rs 875.85. Medplus Health Services Ltd. stock last traded price is 870.90

    Share PriceValue
    Today/Current/Last870.90
    Previous Day875.85

Found Insights useful?

Medplus Health Serv Share Price Returns

1 Day-0.57%
1 Month0.23%
3 Months3.18%
1 Year-2.06%
3 Years11.5%
5 YearsN.A.

Medplus Health Serv Share Recommendations

Mean recosCurrent
STRONG BUY

7 Analysts

Strong
Sell
SellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy5544
Buy2222
Hold----
Sell----
Strong Sell----
# Analysts7766
Recent Recos
  • Target₹820
  • OrganizationHDFC Securities
  • BUY
  • Target₹820
  • OrganizationHDFC Securities
  • BUY
  • Target₹950
  • OrganizationSharekhan by BNP Paribas
  • BUY

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income1,884.981,824.361,696.801,557.651,525.40
    Total Income Growth (%)3.327.528.932.11-3.09
    Total Expenses1,771.161,720.281,599.041,477.521,437.44
    Total Expenses Growth (%)2.967.588.222.79-3.62
    EBIT113.82104.0897.7580.1387.96
    EBIT Growth (%)9.366.4721.99-8.906.52
    Profit after Tax (PAT)63.9857.8155.5042.3651.34
    PAT Growth (%)10.684.1531.03-17.4911.88
    EBIT Margin (%)6.045.705.765.145.77
    Net Profit Margin (%)3.393.173.272.723.37
    Basic EPS (₹)5.334.824.633.544.32
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income250.52225.70208.59186.53204.40
    Total Income Growth (%)11.008.2011.83-8.7514.20
    Total Expenses226.07201.48185.60166.70184.41
    Total Expenses Growth (%)12.218.5511.34-9.6112.03
    EBIT24.4524.2222.9819.8319.99
    EBIT Growth (%)0.965.3915.90-0.8139.03
    Profit after Tax (PAT)16.6716.5815.6313.5313.98
    PAT Growth (%)0.586.0515.50-3.2149.24
    EBIT Margin (%)9.7610.7311.0210.639.78
    Net Profit Margin (%)6.657.347.497.266.84
    Basic EPS (₹)1.391.381.311.131.17
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue6,963.796,184.675,664.864,603.653,810.64
    Total Revenue Growth (%)12.609.1823.0520.8123.29
    Total Expenses6,688.466,001.385,591.424,556.493,692.70
    Total Expenses Growth (%)11.457.3322.7123.3923.27
    Profit after Tax (PAT)219.65150.3265.4749.7695.80
    PAT Growth (%)46.12129.5931.57-48.0650.02
    Operating Profit Margin (%)5.744.653.022.854.87
    Net Profit Margin (%)3.182.441.161.092.53
    Basic EPS (₹)18.3312.575.484.178.55
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue871.33722.03474.32230.17155.26
    Total Revenue Growth (%)20.6852.22106.0848.25120.47
    Total Expenses788.16670.86467.28222.58149.68
    Total Expenses Growth (%)17.4843.57109.9448.7189.49
    Profit after Tax (PAT)62.4140.349.585.545.58
    PAT Growth (%)54.73320.9972.82-0.63-
    Operating Profit Margin (%)10.638.383.306.605.63
    Net Profit Margin (%)7.255.652.052.593.82
    Basic EPS (₹)5.213.370.800.460.50

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent 1.75% of its operating revenues towards interest expenses and 12.83% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets3,932.533,360.103,004.802,796.722,594.05
    Total Assets Growth (%)17.0411.827.447.8165.68
    Total Liabilities1,957.871,620.201,427.441,306.221,176.80
    Total Liabilities Growth (%)20.8413.509.2811.0041.01
    Total Equity1,974.651,739.901,577.361,490.501,417.25
    Total Equity Growth (%)13.4910.305.835.17293.36
    Current Ratio (x)3.003.202.983.112.92
    Total Debt to Equity (x)0.000.000.000.000.10
    Contingent Liabilities0.0014.6516.6618.2432.84
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets1,465.001,399.451,312.231,271.941,187.45
    Total Assets Growth (%)4.686.653.177.12116.52
    Total Liabilities148.88159.10139.60130.6674.67
    Total Liabilities Growth (%)-6.4213.976.8474.98141.34
    Total Equity1,316.111,240.351,172.631,141.281,112.78
    Total Equity Growth (%)6.115.782.752.56658.70
    Current Ratio (x)5.594.003.153.1420.37
    Total Debt to Equity (x)0.000.000.000.000.00
    Contingent Liabilities0.00-0.602.25199.18

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities495.58540.43143.7490.41169.89
    Net Cash used in Investing Activities-127.72-317.61-82.80429.44-703.13
    Net Cash flow from Financing Activities-255.51-227.98-198.10-170.25440.43
    Net Cash Flow112.36-5.16-137.17349.60-92.81
    Closing Cash & Cash Equivalent198.4186.0591.21228.38-121.23
    Closing Cash & Cash Equivalent Growth (%)130.57-5.65-60.06-288.39326.57
    Total Debt/ CFO (x)0.000.000.000.000.84
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities61.9846.687.6711.41-20.71
    Net Cash used in Investing Activities-22.03-39.19-24.4331.72-633.66
    Net Cash flow from Financing Activities-4.79-9.91-5.95-8.36568.63
    Net Cash Flow35.15-2.42-22.7034.77-85.74
    Closing Cash & Cash Equivalent46.4511.3013.0035.700.94
    Closing Cash & Cash Equivalent Growth (%)311.09-13.08-63.593,706.29-98.92
    Total Debt/ CFO (x)0.000.000.000.000.00

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Decrease in Cash from Investing

      Company has used Rs 127.72 cr for investing activities which is an YoY decrease of 59.79%. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)11.118.634.143.336.75
    Return on Capital Employed (%)12.2010.276.855.619.05
    Return on Assets (%)5.584.472.171.773.69
    Interest Coverage Ratio (x)5.635.224.093.754.57
    Asset Turnover Ratio (x)1.891.931.941.690.11
    Price to Earnings (x)45.8760.61126.58156.25126.58
    Price to Book (x)5.095.225.225.218.50
    EV/EBITDA (x)14.1416.2820.5524.0140.04
    EBITDA Margin (%)9.848.737.006.848.03
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)4.743.250.810.480.50
    Return on Capital Employed (%)6.524.491.221.150.71
    Return on Assets (%)4.262.880.730.430.46
    Interest Coverage Ratio (x)14.1810.064.714.504.88
    Asset Turnover Ratio (x)0.600.530.360.170.17
    Price to Earnings (x)161.29227.27909.091,428.572,500.00
    Price to Book (x)7.647.337.036.8110.83
    EV/EBITDA (x)84.15104.16206.47260.83937.93
    EBITDA Margin (%)13.6912.168.4813.768.81

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

Peer Comparison

Found Peer Comparison useful?

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters4,82,80,79140.22 %-0.07
    Pledge2,93,27,92560.74 %0.00
    FII1,86,43,97615.53 %-1.29
    DII3,33,93,61127.82 %1.23
    MF2,71,27,73522.60 %1.12
    Others1,97,36,26416.43 %0.12
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters40.2240.2940.2940.32
    Pledge60.7460.7459.3459.34
    FII15.5316.8316.5316.43
    DII27.8226.5826.5126.02
    Mutual Funds22.6021.4821.4821.47
    Others16.4316.3016.6717.23

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Corporate Actions

  • Board Meeting

    Audited Results

    May 04, 2026

    Board Meeting

    Audited Results

    May 04, 2026

    General Meeting

    -

    Feb 25, 2026

  • Announced onMeeting on
    May 04, 2026May 29, 2026
    Audited Results
    May 04, 2026May 20, 2026
    Audited Results
    Jan 05, 2026Jan 30, 2026
    Quarterly Results
    Oct 01, 2025Oct 31, 2025
    Quarterly Results
    Jul 10, 2025Aug 02, 2025
    Quarterly Results
  • No Data Available

  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Feb 25, 2026Mar 28, 2026
    -
    Aug 22, 2025Sep 15, 2025
    -
    Feb 11, 2025Mar 14, 2025
    -
    Aug 02, 2024Sep 26, 2024
    -
    Nov 13, 2023Dec 15, 2023
    -

About Medplus Health Serv

Medplus Health Services Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 10,514.99 Crore) operating in Retail sector.

Show More

Key Indices Listed On

BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Consumer Discretionary, BSE 400 MidSmallCap Index

Address

H. No: 11-6-56, Survey No: 257 & 258/1,Opp: IDPL Railway Siding Road,Hyderabad, Telangana - 500037

Executive Leadership

GM

Gangadi Madhukar Reddy

Chairman & M.D & CEO
CB

Cherukupalli Bhaskar Reddy

Whole Time Director & COO
AS

Aparna Surabhi

Ind. Non-Executive Director
MG

Madhavan Ganesan

Ind. Non-Executive Director
Show More

Auditors

BSR & Co.
B S R & Associates LLP

FAQs about Medplus Health Serv share

  • 1. What is Medplus Health Serv share price and what are the returns for Medplus Health Serv share?
    As on 12 Jun, 2026, 12:39 PM IST Medplus Health Serv share price is down by 0.57% basis the previous closing price of Rs 859.45. Medplus Health Serv share price is Rs 870.90. Return Performance of Medplus Health Serv Shares:
    • 1 Week: Medplus Health Serv share price moved up by 1.42%
  • 2. What is Medplus Health Serv's 52 week high / low?
    52 Week high of Medplus Health Serv share is Rs 1,022.20 while 52 week low is Rs 732.00
  • 3. What is the market cap of Medplus Health Serv?
    Within the Retail sector, Medplus Health Serv stock has a market cap rank of 5. Medplus Health Serv has a market cap of Rs 10,429.15 Cr.
  • 4. What is the PE & PB ratio of Medplus Health Serv?
    The PE ratio of Medplus Health Serv stands at 47.87, while the PB ratio is 5.32.
  • 5. What are the returns for Medplus Health Serv share?
    Return Performance of Medplus Health Serv Shares:
    • 1 Week: Medplus Health Serv share price moved up by 1.42%

Top Gainers

As on 12:39 PM | 12 Jun 2026
IFCI
84.57
14.09 (20.00%)
Authum Investment
518.75
58.81 (12.79%)
Netweb Technologies
4,585.10
393.71 (9.40%)
Data Patterns (India)
4,546.10
341.11 (8.12%)
MMTC
67.98
4.92 (7.79%)

Top Losers

As on 12:39 PM | 12 Jun 2026
Minda Ind.
1,033.50
-33.80 (-3.17%)
ONGC
244.70
-7.91 (-3.13%)
Oil India Ltd
418.25
-11.11 (-2.59%)
Signatureglobal India
758.75
-19.00 (-2.45%)
OneSource Specialty
1,616.00
-35.41 (-2.15%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.